ULS (UL Solutions Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by ULS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-14 | Friedrich Hecker | Director | A | — | — |
| 2026-09-14 | MICHAEL H THAMAN | Director | A | — | — |
| 2026-09-14 | Linda S Chapin | EVP & CHRO | A | — | — |
| 2026-09-14 | Ryan D Robinson | Executive VP & CFO | A | — | — |
| 2026-09-14 | JAMES P DOLLIVE | Director | A | — | — |
| 2026-09-14 | Charles W Hooper | Director | A | — | — |
| 2026-09-14 | Vikram Kini | Director | A | — | — |
| 2026-09-14 | Alex Dadakis | See Remarks | A | — | — |
| 2026-09-14 | KEVIN KENNEDY | Director | A | — | — |
| 2026-09-14 | Gitte Schjotz | See Remarks | A | — | — |
| 2026-09-14 | MARLA C GOTTSCHALK | Director | A | — | — |
| 2026-09-14 | James M Shannon | Director | A | — | — |
| 2026-09-14 | Jennifer F. Scanlon | President and CEO | A | — | — |
| 2026-09-14 | SALLY SUSMAN | Director | A | — | — |
| 2026-09-14 | GEORGE A WILLIAMS | Director | A | — | — |
| 2026-09-14 | KAREN K PEPPING | Senior VP & CAO | A | — | — |
| 2026-09-14 | Scott D'Angelo | EVP, CLO & Corporate Secy | A | — | — |
| 2026-09-14 | John A Genovesi | See Remarks | A | — | — |
| 2026-09-14 | Alberto Uggetti | EVP & CCO | A | — | — |
| 2026-09-14 | Elisabeth Torstad | Director | A | — | — |
| 2026-09-03 | Jennifer F. Scanlon | President and CEO | Sell | — | — |
| 2026-08-10 | James M Shannon | Director | G | — | — |
| 2026-08-05 | Jennifer F. Scanlon | President and CEO | Sell | — | — |
| 2026-07-08 | MICHAEL H THAMAN | Director | A | — | — |
| 2026-07-08 | Vikram Kini | Director | A | — | — |
| 2026-07-02 | Jennifer F. Scanlon | President and CEO | Sell | — | — |
| 2026-06-10 | JAMES P DOLLIVE | Director | A | — | — |
| 2026-06-10 | MICHAEL H THAMAN | Director | A | — | — |
| 2026-06-10 | SALLY SUSMAN | Director | A | — | — |
| 2026-06-10 | John A Genovesi | See Remarks | A | — | — |
| 2026-06-10 | James M Shannon | Director | A | — | — |
| 2026-06-10 | Jennifer F. Scanlon | President and CEO | A | — | — |
| 2026-06-10 | Ryan D Robinson | Executive VP & CFO | A | — | — |
| 2026-06-10 | KAREN K PEPPING | Senior VP & CAO | Sell | — | — |
| 2026-06-10 | Linda S Chapin | EVP & CHRO | A | — | — |
| 2026-06-10 | Gitte Schjotz | See Remarks | A | — | — |
| 2026-06-10 | Scott D'Angelo | EVP, CLO & Corporate Secy | A | — | — |
| 2026-06-10 | Charles W Hooper | Director | A | — | — |
| 2026-06-10 | Alex Dadakis | See Remarks | A | — | — |
| 2026-06-10 | Vikram Kini | Director | A | — | — |
| 2026-06-10 | GEORGE A WILLIAMS | Director | A | — | — |
| 2026-06-10 | Friedrich Hecker | Director | A | — | — |
| 2026-06-10 | MARLA C GOTTSCHALK | Director | A | — | — |
| 2026-06-10 | Lynn H Hancock | See Remarks | A | — | — |
| 2026-06-10 | KEVIN KENNEDY | Director | A | — | — |
| 2026-06-10 | Elisabeth Torstad | Director | A | — | — |
| 2026-06-10 | Alberto Uggetti | EVP & CCO | A | — | — |
| 2026-06-04 | Gitte Schjotz | See Remarks | Sell | — | — |
| 2026-06-03 | Jennifer F. Scanlon | President and CEO | Sell | — | — |
| 2026-06-02 | Ryan D Robinson | Executive VP & CFO | G | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 1,875,000 | — |
| — | President and CEO | 230,514 | — |
| — | Executive VP & CFO | 166,514 | — |
| — | Director | 112,069 | — |
| — | Director | 79,160 | — |
| — | Director | 71,428 | — |
| — | See Remarks | 59,341 | — |
| — | See Remarks | 46,361 | — |
| — | Director | 35,714 | — |
| — | See Remarks | 31,013 | — |
| — | EVP & CHRO | 22,918 | — |
| — | See Remarks | 21,904 | — |
| — | Director | 18,446 | — |
| — | EVP & CLO | 17,857 | — |
| — | Director | 16,660 | — |
| — | Director | 8,928 | — |
| — | Senior VP & CAO | 8,082 | — |
| — | EVP & CCO | 7,962 | — |
| — | Director | 6,542 | — |
| — | See Remarks | 5,806 | — |
| — | Director | 5,770 | — |
| — | Director | 3,571 | — |
| — | Director | 3,571 | — |
| — | EVP, CLO & Corporate Secy | 3,227 | — |
| — | Director | 2,805 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ULS quote page; the site-wide leaderboard is on the insider transactions hub.